| Literature DB >> 29093274 |
Andrew K Edwards1, Kyle Glithero1,2, Peter Grzesik1,3, Alison A Kitajewski1,4, Naikhoba Co Munabi1,5, Krista Hardy1,6, Qian Kun Tan1, Michael Schonning1, Thaned Kangsamaksin7, Jan K Kitajewski8,9, Carrie J Shawber1,8, June K Wu1.
Abstract
Infantile hemangioma (IH) is a vascular tumor that begins with rapid vascular proliferation shortly after birth, followed by vascular involution in early childhood. We have found that NOTCH3, a critical regulator of mural cell differentiation and maturation, is expressed in hemangioma stem cells (HemSCs), suggesting that NOTCH3 may function in HemSC-to-mural cell differentiation and pathological vessel stabilization. Here, we demonstrate that NOTCH3 is expressed in NG2+PDGFRβ+ perivascular HemSCs and CD31+GLUT1+ hemangioma endothelial cells (HemECs) in proliferating IHs and becomes mostly restricted to the αSMA+NG2loPDGFRβlo mural cells in involuting IHs. NOTCH3 knockdown in HemSCs inhibited in vitro mural cell differentiation and perturbed αSMA expression. In a mouse model of IH, NOTCH3 knockdown or systemic expression of the NOTCH3 inhibitor, NOTCH3 Decoy, significantly decreased IH blood flow, vessel caliber, and αSMA+ perivascular cell coverage. Thus, NOTCH3 is necessary for HemSC-to-mural cell differentiation, and adequate perivascular cell coverage of IH vessels is required for IH vessel stability.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29093274 PMCID: PMC5752265 DOI: 10.1172/jci.insight.93764
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708